Fresenius SE KGaAXSWX:FRE 71 EV-to-FCF is 21.79 as of Jun. 24, 2026, which is 14% above its 10-year median of 19.13. GuruFocus rates XSWX:FRE with a GF Score™ of 71/100 and a GF Value™ of CHF32.85 (Fairly Valued). The stock has 5 warning signs investors should review. Among 410 Healthcare Providers & Services companies, Fresenius SE KGaA ranks worse than 61.22% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Fresenius SE KGaA's Enterprise Value is CHF28,754 Mil.
Fresenius SE KGaA's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was CHF1,319 Mil. Therefore, Fresenius SE KGaA's EV-to-FCF for today is 21.79.
The historical rank and industry rank for Fresenius SE KGaA's EV-to-FCF or its related term are showing as below:
XSWX:FRE'
s EV-to-FCF Range Over the Past 10 Years
Min: -106.13 Med: 19.13 Max: 115.85
Current: 21.96
During the past 13 years, the highest EV-to-FCF of Fresenius SE KGaA was 115.85. The lowest was -106.13. And the median was 19.13.
XSWX:FRE's EV-to-FCF is ranked worse than 61.22% of 410
companies
in the Healthcare Providers & Services industry
Industry Median: 17.47
vs XSWX:FRE: 21.96
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Fresenius SE KGaA (XSWX:FRE) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Fresenius SE KGaA's PE Ratio (TTM) for today is calculated as:
Fresenius SE KGaA's share price for today is CHF35.86.
Fresenius SE KGaA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF2.412.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Fresenius SE KGaA EV-to-FCF Related Terms
Fresenius SE KGaA EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Fresenius SE KGaA's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Fresenius SE KGaA's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fresenius SE KGaA EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Fresenius SE KGaA's EV-to-FCF falls into.
Fresenius SE KGaA's current Enterprise Value is CHF28,754 Mil.
Fresenius SE KGaA's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF1,319 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fresenius SE KGaA (XSWX:FRE) has a EV-to-FCF of 21.79 as of Jun. 24, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Fresenius SE KGaA and its competitors. This is 14% above median its historical median of 19.13. According to the industry distribution chart, Fresenius SE KGaA ranks #251 out of 410 companies in the Healthcare Providers & Services industry, placing it in the top 61.2%.
Is Fresenius SE KGaA's EV-to-FCF too high?
Fresenius SE KGaA's current EV-to-FCF of 21.79 is 14% above median its 10-year median of 19.13. The Healthcare Providers & Services industry median EV-to-FCF is 17.47. Fresenius SE KGaA's value of 21.79 is 24.7% above this industry median. Based on the distribution chart, Fresenius SE KGaA ranks #251 out of 410 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Fresenius SE KGaA has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius SE KGaA's EV-to-FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius SE KGaA ranks #251 out of 410 companies for EV-to-FCF. This places Fresenius SE KGaA in the lower half of its industry. The industry median EV-to-FCF is 17.47. Fresenius SE KGaA's value of 21.79 is 24.7% above this benchmark. While the company's 10-year median is 19.13 vs. the industry median of 17.47, Fresenius SE KGaA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.47, based on 410 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fresenius SE KGaA's current EV-to-FCF of 21.79 is 24.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Fresenius SE KGaA and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fresenius SE KGaA's current EV-to-FCF is 21.79, which is 14% above median its own 10-year median of 19.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius SE KGaA stock overvalued right now?
Based on GuruFocus' analysis, Fresenius SE KGaA (XSWX:FRE) is currently considered Fairly Valued. The stock's GF Value™ is CHF32.85, compared to a current price of CHF35.86 — trading 9.2% above its estimated fair value. The current EV-to-FCF is 21.79, which is 14% above median its 10-year median of 19.13 and 24.7% above the Healthcare Providers & Services industry median of 17.47. Fresenius SE KGaA's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Fresenius SE KGaA (XSWX:FRE), the current EV-to-FCF is 21.79 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fresenius SE KGaA (XSWX:FRE) Overvalued in 2026?
Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued.
The current stock price of CHF35.86 is trading 9.2% above its estimated GF Value™ of CHF32.85.
GuruFocus considers Fresenius SE KGaA to be Fairly Valued.
Key valuation signals for XSWX:FRE:
EV-to-FCF: 21.79 (14% above median its 10-year median of 19.13)
GF Value™: CHF32.85 vs. price of CHF35.86 (9.2% above fair value)
Industry Position: 24.7% above the Healthcare Providers & Services median (#251 of 410)
No single metric tells the full story. See the XSWX:FRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
71GF Score
Get the complete analysis for XSWX:FRE
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:FRE has been successfully added to your 
